Quick Takeaways
- Paradigm Biocapital Advisors LP filed SCHEDULE 13G for EyePoint, Inc. Common Stock, $0.001 par value per share (EYPT).
- Disclosed ownership: 5.1%.
- Date of event: 17 Feb 2026.
Paradigm Biocapital Advisors LP - 17 Feb 2026 SCHEDULE 13G Report for EyePoint, Inc. Common Stock, $0.001 par value per share (EYPT)
- Filing Manager
- Paradigm Biocapital Advisors LP
- Reporting Manager
- Paradigm BioCapital Advisors LP
- Symbol
- EYPT
- Shares outstanding
- 82,201,196 shares
- Disclosed Ownership
- 4,192,261 shares
- Ownership
- 5.1%
- Form type
- SCHEDULE 13G
- Filing time
- 24 Feb 2026, 16:00:49 UTC
- Date of event
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Paradigm Biocapital Advisors LP disclosed 5.1% ownership in EyePoint, Inc. Common Stock, $0.001 par value per share (EYPT) on 17 Feb 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 24 Feb 2026, 16:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Paradigm BioCapital Advisors LP | 5.1% | 4,192,261 | 4,192,261 | 0 | /s/ David K. Kim | David K. Kim / Authorized Signatory | |
| Paradigm BioCapital Advisors GP LLC | 5.1% | 4,192,261 | 4,192,261 | 0 | /s/ David K. Kim | David K. Kim / Authorized Signatory | |
| Senai Asefaw, M.D. | 5.1% | 4,192,261 | 4,192,261 | 0 | /s/ Senai Asefaw, M.D. | N/A | |
| Paradigm BioCapital International Fund Ltd. | 4.5% | 3,694,542 | 3,694,542 | 0 | /s/ David K. Kim | David K. Kim / Authorized Signatory |